Earlier, Swiss newspaper Tages-Anzeiger reported the Basel-based drugmaker was preparing to split off Sandoz, citing an employee representative as well as participants in a Novartis investor event last week in London.
Novartis ‘completely committed’ to Sandoz, has no split-off plan
More from Industry NewsMore posts in Industry News »
- Aurobindo, Unichem recall products in US market
- After recommending booster dose for 40+, INSACOG says more experiments needed
- Omicron scare: Experts advise booster doses for health workers
- BioNTech CEO confident of quickly adapting vaccine for Omicron
- Double vaccinate against Covid first, experts say amid calls for booster shots